Search filters

List of works by David Rizzieri

"Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma

scientific article

13th International Conference on Malignancies in AIDS and Other Acquired Immunodeficiencies (ICMAOI) Bethesda, MD, USA. 7-8 November 2011. Abstracts

article

4-hydroperoxycyclophosphamide--purged peripheral blood stem cells for autologous transplantation in patients with acute myeloid leukemia

scientific article published in March 2003

A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Myelodysplastic Syndromes Patients

scientific article published on 08 August 2020

A Phase I Study of Arsenic Trioxide (Trisenox), Ascorbic Acid, and Bortezomib (Velcade) Combination Therapy in Patients With Relapsed/Refractory Multiple Myeloma ⬇️

scientific article published on February 13, 2013

A Phase II Trial of Gemcitabine and Mitoxantrone for Patients With Acute Myeloid Leukemia in First Relapse ⬇️

scientific article published on December 1, 2010

A multi-center Phase 1 trial of ipilimumab in myelodysplastic syndrome patients following hypomethylating agent failure.

scientific article published in May 2018

A multicenter, phase II study of maintenance azacitidine in older patients with acute myeloid leukemia in complete remission after induction chemotherapy.

scientific article

A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies

scientific article

A phase 2 study of mocetinostat, a histone deacetylase inhibitor, in relapsed or refractory lymphoma

scientific article published on 25 April 2017

A phase II study of elacytarabine in combination with idarubicin and of human equilibrative nucleoside transporter 1 expression in patients with acute myeloid leukemia and persistent blasts after the first induction course

scientific article published on 24 January 2014

Adult Umbilical Cord Blood Transplantation Using Myeloablative Thiotepa, Total Body Irradiation, and Fludarabine Conditioning

scientific article published on 17 July 2017

Adult dual umbilical cord blood transplantation using myeloablative total body irradiation (1350 cGy) and fludarabine conditioning

scientific article published on 22 September 2010

Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimens

scientific article published on 01 August 2004

Age-specific differences in oncogenic pathway dysregulation and anthracycline sensitivity in patients with acute myeloid leukemia

scientific article published on 26 October 2009

Alemtuzumab for the prevention and treatment of graft-versus-host disease ⬇️

scientific article published on 03 March 2011

Alemtuzumab in relapsed or refractory chronic lymphocytic leukemia and prolymphocytic leukemia

scientific article published on May 2002

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

scientific article

Allogeneic hematopoietic cell transplantation for chemotherapy-unresponsive mantle cell lymphoma: a cohort analysis from the center for international blood and marrow transplant research

scientific article published on 17 January 2013

Allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors

scientific article published on November 2007

Alternate donor hematopoietic cell transplantation (HCT) in non-Hodgkin lymphoma using lower intensity conditioning: a report from the CIBMTR

scientific article published on 07 December 2011

Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donor.

scientific article published on 17 November 2014

An open-label phase 2 study of glycogen synthase kinase-3 inhibitor LY2090314 in patients with acute leukemia

scientific article

Anti proliferative activity of ELACY (CP-4055) in combination with cloretazine (VNP40101M), idarubicin, gemcitabine, irinotecan and topotecan in human leukemia and lymphoma cells

scientific article published on April 2008

Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant

scientific article published on 04 June 2020

Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: a NLCS and CIBMTR Analysis.

scientific article published on 11 December 2017

Autologous and allogeneic transplantation for burkitt lymphoma outcomes and changes in utilization: a report from the center for international blood and marrow transplant research

scientific article published on 27 November 2012

Autologous haematopoietic cell transplantation for non-Hodgkin lymphoma with secondary CNS involvement

scientific article published on 06 July 2013

Autologous or reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chemotherapy-sensitive mantle-cell lymphoma: analysis of transplantation timing and modality

scientific article published on 16 December 2013

Bendamustine, pomalidomide, and dexamethasone for relapsed and/or refractory multiple myeloma

scientific article published on 31 July 2018

Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases

scientific article published on 01 June 2003

CD52 expression in mantle cell lymphoma

scientific article published on 01 February 2002

CD98-Mediated Adhesive Signaling Enables the Establishment and Propagation of Acute Myelogenous Leukemia

scientific article published on 27 October 2016

Camidanlumab tesirine, an antibody-drug conjugate, in relapsed/refractory CD25-positive acute myeloid leukemia or acute lymphoblastic leukemia: A phase I study

scientific article published on 07 June 2020

Chemoimmunotherapy's potential to impact paroxysmal nocturnal hemoglobinuria

scientific article published on February 1, 2012

Clinical and Neuroimaging Correlates of Post-Transplant Delirium

scientific article published on 19 September 2020

Clinical and molecular predictors of disease severity and survival in chronic lymphocytic leukemia

scientific article published in December 2007

Clinical potential of elacytarabine in patients with acute myeloid leukemia

scientific article

Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial

scientific article

Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia

scientific article published on 04 December 2006

Community health status and outcomes after allogeneic hematopoietic cell transplantation in the United States

scientific article published on 21 October 2020

Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis

scientific article

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS

scientific article published on 01 October 2020

Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission

scientific article

Consolidation with high-dose combination alkylating agents with bone marrow transplantation significantly improves disease-free survival in hormone-insensitive metastatic breast cancer in complete remission compared with intensive standard-dose chem

scientific article published in February 2006

Cyclophosphamide-based hematopoietic stem cell mobilization before autologous stem cell transplantation in newly diagnosed multiple myeloma

scientific article published on 8 October 2014

Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis

scientific article published on 24 January 2017

Deep sequencing of the small RNA transcriptome of normal and malignant human B cells identifies hundreds of novel microRNAs

scientific article

Dendritic cell recovery following nonmyeloablative allogeneic stem cell transplants

scientific article published in August 2002

Differential impact of inhibitory and activating Killer Ig-Like Receptors (KIR) on high-risk patients with myeloid and lymphoid malignancies undergoing reduced intensity transplantation from haploidentical related donors ⬇️

scientific article published on December 5, 2011

Disabling immune tolerance by programmed death-1 blockade with pidilizumab after autologous hematopoietic stem-cell transplantation for diffuse large B-cell lymphoma: results of an international phase II trial

scientific article published on 14 October 2013

Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature

scientific article

Dose, schedule, safety, and efficacy of guadecitabine in relapsed or refractory acute myeloid leukemia.

scientific article published on 6 December 2017

Dose-intense chemoimmunotherapy plus radioimmunotherapy in high-risk diffuse large B-cell lymphoma and mantle cell lymphoma: a phase II study.

scientific article published on 21 February 2018

Dose-intense cyclophosphamide and etoposide for patients with refractory or high-risk non-Hodgkin's lymphoma

scientific article published in September 2004

Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation

scientific article

Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma

scientific article published on 20 September 2010

Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myeloma.

scientific article published on 19 January 2017

Elacytarabine has single‐agent activity in patients with advanced acute myeloid leukaemia ⬇️

scientific article published on June 15, 2012

Elacytarabine, a novel 5′-elaidic acid derivative of cytarabine, and idarubicin combination is active in refractory acute myeloid leukemia ⬇️

scientific article published on January 9, 2012

Engineering a BCR-ABL-activated caspase for the selective elimination of leukemic cells

scientific article published on 16 January 2013

Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells

scientific article

Feasibility of Low-Dose Interleukin-2 Therapy Following T-Cell-Depleted Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation From HLA-Matched or -Mismatched Family Member Donors ⬇️

scientific article published on January 1, 2011

Fludarabine-based nonmyeloablative stem cell transplantation for sickle cell disease with and without renal failure: clinical outcome and pharmacokinetics

scientific article

Genetic heterogeneity of diffuse large B-cell lymphoma

scientific article published on 4 January 2013

Guadecitabine (SGI-110) in treatment-naive patients with acute myeloid leukaemia: phase 2 results from a multicentre, randomised, phase 1/2 trial

scientific article published on 24 August 2017

HLA-Mismatched Microtransplant in Older Patients Newly Diagnosed With Acute Myeloid Leukemia: Results From the Microtransplantation Interest Group

scientific article published on 14 September 2017

Haploidentical transplantation for leukemia.

scientific article published on September 2010

Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia

scientific article

Hematologic engraftment and reconstitution of immune function post unrelated placental cord blood transplant in an adult with acute lymphocytic leukemia ⬇️

scientific article published on 01 March 1998

Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.

scientific article

High-dose BCNU/Melphalan conditioning regimen before autologous stem cell transplantation in newly diagnosed multiple myeloma.

scientific article

High-dose chemotherapy and hematopoietic support for patients with high-risk primary breast cancer and involvement of 4 to 9 lymph nodes

scientific article published in January 2002

High-dose cyclophosphamide and etoposide for patients with refractory acute myeloid leukemia: a case series

scientific article published in August 2003

Histone H4 acetylation by immunohistochemistry and prognosis in relapsed acute lymphocytic leukaemia (ALL) ⬇️

scientific article published on March 6, 2011

Identification of compounds that enhance the anti-lymphoma activity of rituximab using flow cytometric high-content screening

scientific article published in September 2004

Immune recovery in adult patients after myeloablative dual umbilical cord blood, matched sibling, and matched unrelated donor hematopoietic cell transplantation

scientific article

Immunotherapeutic applications of NK cells

scientific article

Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blo

scientific article published on 26 September 2019

Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation

scientific article

Impact of pretransplantation conditioning regimens on outcomes of allogeneic transplantation for chemotherapy-unresponsive diffuse large B cell lymphoma and grade III follicular lymphoma

scientific article published on February 2013

Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia

scientific article

Implementation of management guidelines for chronic myeloid leukemia: perspectives in the United States.

scientific article

Improved efficacy using rituximab and brief duration, high intensity chemotherapy with filgrastim support for Burkitt or aggressive lymphomas: cancer and Leukemia Group B study 10 002.

scientific article published on 15 January 2014

Increased BCR responsiveness in B cells from patients with chronic GVHD.

scientific article published on 14 February 2014

Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States

scientific article

Individualizing Treatment Decisions for Older Adults with Hematologic Malignancies ⬇️

scientific article published on January 1, 2013

Insight into the molecular pathophysiology of myelodysplastic syndromes: targets for novel therapy

scientific article published on 5 May 2016

Intensive chemotherapy with and without cranial radiation for Burkitt leukemia and lymphoma: final results of Cancer and Leukemia Group B Study 9251.

scientific article

Is timing everything?

scientific article published on 14 December 2013

Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia

scientific article

Low-dose weekly paclitaxel for recurrent or refractory aggressive non-Hodgkin lymphoma

scientific article published on 01 June 2004

MDS: unraveling the mystery ⬇️

scientific article published on December 13, 2012

Microbe-derived short chain fatty acids butyrate and propionate are associated with protection from chronic GVHD

scientific article published on 19 May 2020

Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects

scientific article published on 12 March 2020

Mini Test Dose of Intravenous Busulfan (Busulfex®) in Allogeneic Non-Myeloablative Stem Cell Transplantation, Followed by Liquid Chromatography Tandem-Mass Spectrometry ⬇️

scientific article published on September 28, 2012

Mobilization of dendritic cells from patients with breast cancer into peripheral blood stem cell leukapheresis samples using Flt-3-Ligand and G-CSF or GM-CSF

scientific article published on 01 April 2002

Molecular Measurable Residual Disease Testing of Blood During AML Cytotoxic Therapy for Early Prediction of Clinical Response

Morphologic examination of sequential bone marrow biopsies after nonmyeloablative stem cell transplantation complements molecular studies of donor engraftment

scientific article published on 01 October 2006

Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myeloid Leukemia and Myelodysplastic Syndromes with Low/Intermediate, but not High Disease Risk Index: A CIBMTR Study: Superior DFS with MA

scientific article published on 30 September 2020

Myeloablative conditioning with total body irradiation for AML: Balancing survival and pulmonary toxicity.

scientific article published on 15 July 2016

Myeloablative intravenous busulfan/fludarabine conditioning does not facilitate reliable engraftment of dual umbilical cord blood grafts in adult recipients

scientific article

Natural killer cell-enriched donor lymphocyte infusions from A 3-6/6 HLA matched family member following nonmyeloablative allogeneic stem cell transplantation

scientific article published on 24 February 2010

New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation

scientific article published on February 2013

Nonmyeloablative regimen preserves "niches" allowing for peripheral expansion of donor T-cells

scientific article published on 01 January 2002

Optimal donor for African Americans with hematologic malignancy: HLA-haploidentical relative or umbilical cord blood transplant

scientific article published on 07 July 2020

Outcomes of Maintenance Therapy with Bortezomib after Autologous Stem Cell Transplantation for Patients with Multiple Myeloma

scientific article published on 14 November 2016

Outcomes of a 1-day nonmyeloablative salvage regimen for patients with primary graft failure after allogeneic hematopoietic cell transplantation

scientific article published on August 2011

Outcomes of a second non-myeloablative allogeneic stem cell transplantation following graft rejection

scientific article published on 5 November 2007

Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission

scientific article published on 01 June 2019

Outcomes of hematopoietic cell transplantation for diffuse large B cell lymphoma transformed from follicular lymphoma.

scientific article

Outcomes of patients who undergo aggressive induction therapy for secondary acute myeloid leukemia

scientific article published on 01 July 2009

Overcoming drug resistance in mantle cell lymphoma using a combination of dose-dense and intense therapy

scientific article published in July 2010

Partially matched, nonmyeloablative allogeneic transplantation: clinical outcomes and immune reconstitution

scientific article

Patterns of microRNA expression characterize stages of human B-cell differentiation.

scientific article published on 06 February 2009

Phase 1 trial study of 131I-labeled chimeric 81C6 monoclonal antibody for the treatment of patients with non-Hodgkin lymphoma

scientific article published on 20 April 2004

Phase I Study of the Combination of Bendamustine, Rituximab, and Pixantrone in Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

scientific article published on 29 July 2018

Phase I clinical study of diphtheria toxin-interleukin 3 fusion protein in patients with acute myeloid leukemia and myelodysplasia

scientific article published on 01 March 2008

Phase I dose escalation study of naive T-cell depleted donor lymphocyte infusion following allogeneic stem cell transplantation

scientific article published on 05 July 2020

Phase I evaluation of gemcitabine, mitoxantrone, and their effect on plasma disposition of fludarabine in patients with relapsed or refractory acute myeloid leukemia

scientific article published on August 2008

Phase I evaluation of prolonged-infusion gemcitabine with fludarabine for relapsed or refractory acute myelogenous leukemia

scientific article

Phase I evaluation of prolonged-infusion gemcitabine with irinotecan for relapsed or refractory leukemia or lymphoma

scientific article published in July 2002

Phase I evaluation of prolonged-infusion gemcitabine with mitoxantrone for relapsed or refractory acute leukemia

scientific article published in February 2002

Phase I study of temozolomide and laromustine (VNP40101M) in patients with relapsed or refractory leukemia

scientific article published in June 2010

Phase II feasibility and pharmacokinetic study of concurrent administration of trastuzumab and high-dose chemotherapy in advanced HER2+ breast cancer

scientific article published in November 2004

Phase II multicenter study of arsenic trioxide in patients with myelodysplastic syndromes

scientific article

Phase II open label study of the oral vascular endothelial growth factor-receptor inhibitor PTK787/ZK222584 (vatalanib) in adult patients with refractory or relapsed diffuse large B-cell lymphoma ⬇️

scientific article published on April 19, 2013

Phase II study of cenersen, an antisense inhibitor of p53, in combination with fludarabine, cyclophosphamide and rituximab for high-risk chronic lymphocytic leukemia ⬇️

scientific article published on September 23, 2011

Phase III open-label randomized study of cytarabine in combination with amonafide L-malate or daunorubicin as induction therapy for patients with secondary acute myeloid leukemia

scientific article published on 2 March 2015

Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial

scientific article

Plerixafor (a CXCR4 antagonist) following myeloablative allogeneic hematopoietic stem cell transplantation enhances hematopoietic recovery

scientific article published on 17 August 2016

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation

scientific article published in June 2004

Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment

scientific article published on 21 January 2013

Pre-transplant hepatic steatosis (fatty liver) is associated with chronic graft-vs-host disease but not mortality

scientific article published on 11 September 2020

Pre-transplant marital status and hematopoietic cell transplantation outcomes

scientific article published on 01 December 2020

Preclinical evaluation of gemcitabine combination regimens for application in acute myeloid leukemia

scientific article published in June 2005

Preemptive dosing of plerixafor given to poor stem cell mobilizers on day 5 of G-CSF administration ⬇️

scientific article published on November 14, 2011

Prognostic and predictive factors for patients with metastatic breast cancer undergoing aggressive induction therapy followed by high-dose chemotherapy with autologous stem-cell support

scientific article

Prognostic factors for outcomes in allogeneic transplantation for CML in the imatinib era: a CIBMTR analysis

scientific article published on 10 October 2011

Providing personalized prognostic information for adult leukemia survivors

scientific article published on 06 September 2013

Pulmonary sarcoidosis following stem cell transplantation: is it more than a chance occurrence?

scientific article published on 01 August 2004

Radioimmunotherapy for Non-Hodgkin's Lymphoma.

scientific article

Rapid Donor Identification Improves Survival in High-Risk First-Remission Patients With Acute Myeloid Leukemia

scientific article published on 27 January 2020

Rates of deep molecular response by digital and conventional PCR with frontline nilotinib in newly diagnosed chronic myeloid leukemia: a landmark analysis

scientific article published on 26 March 2019

Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia ⬇️

scientific article published on 07 October 2012

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

scientific article published on 01 July 2020

Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignancies

scientific article

Renal Shielding and Dosimetry for Patients With Severe Systemic Sclerosis Receiving Immunoablation With Total Body Irradiation in the Scleroderma: Cyclophosphamide or Transplantation Trial ⬇️

scientific article published on August 26, 2010

Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3-6/6 HLA matched donors

scientific article published on 13 October 2008

Rituximab in Lymphocyte Predominance Hodgkin's Disease: A Case Series ⬇️

scientific article published on September 1, 2003

Safety and tolerability of guadecitabine (SGI-110) in patients with myelodysplastic syndrome and acute myeloid leukaemia: a multicentre, randomised, dose-escalation phase 1 study

scientific article

Safety of growth factor administration for leukapheresis in those with WBC counts greater than 60,000/µl

scientific article published on 28 June 2014

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

scientific article

Secondary myelodysplasia and acute leukemia in breast cancer patients after autologous bone marrow transplant ⬇️

scientific article published on 01 March 1998

Sequential high-dose ifosfamide, carboplatin and etoposide with rituximab for relapsed Hodgkin and large B-cell non-Hodgkin lymphoma: increased toxicity without improvement in progression-free survival

scientific article

Severe pulmonary toxicity after myeloablative conditioning using total body irradiation: an assessment of risk factors

scientific article published on 6 October 2010

Successful allogeneic engraftment of mismatched unrelated cord blood following a nonmyeloablative preparative regimen ⬇️

scientific article published on 01 December 2001

Systematic Dissection of the Metabolic-Apoptotic Interface in AML Reveals Heme Biosynthesis to Be a Regulator of Drug Sensitivity

scientific article published on 14 February 2019

Tagraxofusp in Blastic Plasmacytoid Dendritic-Cell Neoplasm

scientific article published on 01 April 2019

Targeting High Mobility Group Box-1 (HMGB1) Promotes Cell Death in Myelodysplastic Syndrome

article

Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function ⬇️

scientific article published on 04 June 2013

Tenascin and microvessel stromal changes in patients with non-Hodgkin's lymphoma are isolated to the sites of disease and vary in correlation to disease activity

scientific article published in October 2005

Tetraspanin 3 Is Required for the Development and Propagation of Acute Myelogenous Leukemia

scientific article

Thalidomide has limited single-agent activity in relapsed or refractory indolent non-Hodgkin lymphomas: a phase II trial of the Cancer and Leukemia Group B.

scientific article published in February 2008

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

scientific article published on 03 May 2018

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen

scientific article

The genetic landscape of mutations in Burkitt lymphoma

scientific article

The impact of donor type on outcomes and cost of allogeneic hematopoietic cell transplant for pediatric leukemia: a merged CIBMTR and PHIS analysis: Pediatric acute leukemia transplant risks and utilization

scientific article published on 25 May 2020

The outcome of full-intensity and reduced-intensity conditioning matched sibling or unrelated donor transplantation in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia in first and second complete remission

scientific article

Transplantation of Ex Vivo Expanded Umbilical Cord Blood (NiCord) Decreases Early Infection and Hospitalization

scientific article published on 6 April 2017

Treatment of blastic plasmacytoid dendritic cell neoplasm

scientific article published on December 2016

Two dosing regimens of tosedostat in elderly patients with relapsed or refractory acute myeloid leukaemia (OPAL): a randomised open-label phase 2 study

scientific article

Umbilical cord blood expansion with nicotinamide provides long-term multilineage engraftment

scientific article

Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial

scientific article published on August 2016

Unrelated umbilical cord blood transplantation in adult patients

scientific article published in December 2003

Updates in Novel Therapies for Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

scientific article published on 01 December 2019

Use of Cyclosporine Is Associated with the Increase in Pre-Engraftment Syndrome After Myeloablative Dual Cord Blood Transplantation

scholarly article by J. Kanda et al published February 2012 in Biology of Blood and Marrow Transplantation

Vascular endothelial growth factor inhibition is not an effective therapeutic strategy for relapsed or refractory multiple myeloma: a phase 2 study of pazopanib (GW786034).

scientific article published in May 2009

Zevalin(®) (ibritumomab tiuxetan): After more than a decade of treatment experience, what have we learned?

scientific article

Paulina is supported by:

About Paulina

Help